Wang, C.

Long‐term safety with ≥12 months of pirtobrutinib in relapsed/refractory B‐cell malignancies

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 480-481

10.1002/hon.3164_353